On Feb 7, 2022 1859 closed a Series A round and raised $40,000,000 from FusionX Ventures, Northpond Ventures, OMX Ventures, Vertical Venture Partners, featuring lead […]
Series A – 1859
On Feb 7, 2022 1859 closed a Series A round and raised $40,000,000 from FusionX Ventures, Northpond Ventures, OMX Ventures, Vertical Venture Partners, featuring lead […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
